CapyFin

Calendar Reports

Search for a symbol...

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2026 CapyFin. All rights reserved.

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

Evofem Biosciences Fiscal Q2 2023 Earnings Report - CapyFin

Evofem Biosciences

EVFM · NASDAQ🇺🇸

Overview Earnings

Dividends Seasonality Metrics

Q3 2024 -16.45%Q2 2024 +6.38%Q1 2024 -15.27%Q4 2023 +32.42%Q3 2023 0.00%Q2 2023 -13.26%Q1 2023 -9.51%Q3 2022 -19.17%Q4 2022 -19.17%Q2 2022 +8.40%Q1 2022 -18.18%Q4 2021 -17.45%Q3 2021 -16.27%Q2 2021 -10.02%Q1 2021 +16.76%Q4 2020 -36.67%Q3 2020 -3.67%Q2 2020 -5.00%Q1 2020 -1.96%Q4 2019 -19.77%Q3 2019 +0.78%Q2 2019 -10.70%Q1 2019 +31.83%Q4 2018 -20.72%Q3 2018 -9.79%Q2 2018 -5.07%Q1 2018 -11.41%Q4 2017 -3.54%Q3 2017 -3.23%Q2 2017 -17.39%Q1 2017 +2.24%Q4 2016 -2.10%Q3 2016 +0.86%Q2 2016 -11.88%Q1 2016 -6.86%Q4 2015 +4.77%Q3 2015 -6.37%Q2 2015 -0.88%Q1 2015 -2.72%Q4 2014 +6.55%Q3 2014 Q2 2014 Q1 2014 Q4 2013

Jun 30, 2023

•

Jun 30, 2023

Evofem Biosciences Q2 2023 Earnings Report

Previous year: $6.03M

Previous year: -$580

Previous year: $4.75M

Cash and Equivalents

Previous year: $19.9M

Previous year: -$26.8M

Previous year: $21.5M

Evofem Biosciences

Unlock previous datapoints

Evofem Biosciences

Unlock previous datapoints

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Company Overview

Full financial data and analysis

View Evofem Biosciences